Synchron logo

Synchron, Inc.

Biotechnology

Synchron Stock

Synchron is a clinical-stage endovascular brain computer interface (BCI) company focused on helping people with paralysis. Since 2012, the company has been developing a BCI platform that avoids the need for open brain surgery by using a minimally invasive procedure. The Synchron Switch™ BCI is currently in human clinical trials in the US and Australia.

Management Team

Tom Oxley Co-Founder and CEO
Nick Opie Co-Founder and CTO
Amos Meltzer Chief Legal Officer
Kurt Haggstrom Chief Commercial Officer

Notable Investors

Funding Information